Who Owns Cytiva?

What does Danaher Corporation own?
Danaher owns approximately 15 operating companies across three segments. In Biotechnology, it owns Cytiva and Pall Corporation. In Life Sciences, it owns Leica Microsystems, Molecular Devices, Integrated DNA Technologies, SCIEX, and Beckman Coulter Life Sciences. In Diagnostics, it owns Beckman Coulter Diagnostics, Cepheid, Radiometer, Leica Biosystems, and Masimo. It also owns environmental and applied solutions brands including Hach and Videojet.

Is Danaher Corporation publicly traded?
Yes. Danaher Corporation is publicly traded on the New York Stock Exchange under the ticker symbol DHR. The company is a component of the S&P 500 and is owned by institutional investors, mutual funds, and individual shareholders. There is no parent company or controlling shareholder.

Who founded Danaher Corporation?
Danaher was founded in 1969 by brothers Steven M. Rales and Mitchell P. Rales in Washington, D.C. The Rales brothers established the company as a diversified industrial conglomerate and built it into a global life sciences and diagnostics leader through decades of disciplined acquisitions and operational improvement.

Where is Danaher Corporation headquartered?
Danaher is headquartered in Washington, D.C., USA. The company's corporate offices are based in the Washington, D.C. metropolitan area, with operating companies and manufacturing facilities distributed across the United States, Europe, Asia, and the Americas.

How many brands does Danaher Corporation own?
Danaher owns approximately 15 operating companies across its three segments. These include well-known brands in life sciences and diagnostics such as Cytiva, Pall, Leica Microsystems, Beckman Coulter, Cepheid, Radiometer, and Masimo. The company also owns environmental and industrial brands including Hach and Videojet.

Who owns Danaher Corporation?
Danaher is an independent publicly traded corporation with no parent company. The company is owned by institutional investors, mutual funds, and individual shareholders who hold its NYSE-listed common stock. The Rales brothers remain significant shareholders and board members but do not hold a controlling stake. Major institutional holders include Vanguard Group, BlackRock, and State Street Corporation.

What were Danaher's recent financial results?
For FY2025, Danaher reported $24.6 billion in revenue and $3.6 billion in net earnings. In Q2 2026, revenue was $6.3 billion, up 5.5%, with net earnings of $870 million and adjusted EPS of $1.94, up 8.0%. The company raised its 2026 guidance to adjusted EPS of $8.45 to $8.60 and core revenue growth of 3.0% to 4.0%.

Has Danaher made major acquisitions recently?
In June 2026, Danaher completed the acquisition of Masimo Corporation for $9.9 billion, adding pulse oximetry and patient monitoring to its Diagnostics segment. In 2023, Danaher acquired Abcam for approximately $5.7 billion. The largest acquisition in company history was Cytiva (formerly GE Life Sciences) for $21.4 billion in 2016.